MetaXearch > / Biotechnology and Pharmaceuticals / Pharmaceuticals / Cancer /
PNP Therapeutics, Inc.
Company developing gene therapy system, using the E. coli enzyme, purine nucleoside phosphorylase, to induce suicide in tumor cells. Includes technology background, research, patents, publications, key staff, and contacts in Birmingham, Alabama. (infos)Australian Cancer Technology Pty Ltd
Company developing three approaches for cures; Chk1 kinase inhibitor, mutated p53 gene and retroviral display vaccines. Includes announcements, media releases, overview of projects incollaboration with UK, a hospital in Sydney, and corporate details at West Perth, Western Australia. (infos)
Onyvax Ltd.
Conducts research and development for marketing cell-based vaccines and human monoclonal antibody against CD55 in tumour cells. Includes explanation of products in pipeline, and clinical studies in phase II of prostate cancer vaccine at Bournemouth, and their contacts in London, UK. (infos)
Aventis Cancer Vaccine Program
Studying the possibilities of using an immunotherapeutic approach for melanoma, breast and colorectal and tumors. Includes results of clinical research, FAQ, contact form, and profile of research partners in Canada. (infos)
Biomoda, Inc.
Offers products for diagnosis, imaging and treatment of tumors, especially in lung. Technologies in sputum sample and pap smear screening, certifying cell lines, inflammatory focus imaging, Cu-TCPP treatment in pre-clinical development at Albuquerque, New Mexico. (infos)
Crusade Laboratories Ltd.
Start-up focusing on the discovery, development and commercialisation of novel treatments for tumors and neurodegenerative diseases. Includes investor information, technology in GM-HSV targeting glioma and clinical trials in Glasgow, UK. (infos)
Cancer Survival Toolbox
Introduction the mechanisms, with resources in oncology, vascular medicine and immunolgical disease, including possible therapies and links to related organizations, presented by Genentech, Inc. (infos)
InterGenetics Inc.
Company with platform technology, called CombiSNiP, that genetically quantifies an individual's risk for development, and is involved in pharmacogenetics research on treating breast cancer. Includes corporate overview, directions and contacts in Oklahoma City. (infos)
GeneSegue
Focusing on the development of delivery systems to target solid tumors, such as prostate with nanoencapsulated biotherapeutics. Includes brief overview of concepts from Chaska, Minnesota. (infos)
Karyon
Offers products in angiogenesis and cell growth regulation, focusing on protected ligands that target specifically to sarcomas and melanomas. Includes research and technology overview, and information for investors in Helsinki, Finland. (infos)